A congressional committee has announced that it is calling in the head of the Food and Drug Administration (FDA) to testify on hemp regulatory issues as a way to hold him “accountable” amid ongoing industry concerns.
The House Oversight and Accountability Committee, chaired by Rep. James Comer (R-KY), scheduled a hearing with FDA Commissioner Robert Califf on April 11.
Members of the panel will weigh in on “ongoing investigations” into FDA’s “response to several issues, including…hemp regulation,” it said in a notice on Thursday.
“The Oversight Committee has highlighted several crises occurring on the FDA’s watch which have negatively impacted the lives and health of American people and families,” Comer said in the notice. “We will hold the Commissioner accountable for what the FDA is doing to address ongoing crises, how they are conducting inspections to prevent nationwide crises in the future, and how they intend to ensure the FDA is first and foremost protecting American consumers.”
Other issues set to be discussed include drug shortages, tobacco regulation, food safety and infant formula.
This comes nearly a year after a House subcommittee held a first-of-its kind hearing where members examined the impacts of FDA inaction on developing regulations to allow
Read full article on Marijuana Moment
